Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

FDA Safety Communication Updates Stance on Endologix AAA Grafts

L.A. McKeown

January 13, 2022

News Daily News

Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers

Michael O'Riordan

September 23, 2021

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

Caitlin E. Cox

September 29, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Daily News

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Shelley Wood

January 21, 2019

News Daily News

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

Todd Neale

November 26, 2018

News Daily News

Women Likely Not Good Targets for AAA Screening, Study Suggests

Lucy Hicks

August 13, 2018

News Daily News

Screening Programs for Abdominal Aortic Aneurysm Need a Rethink, Swedish Study Contends

Shelley Wood

June 15, 2018

News Daily News

FDA Advisory Panel Gives Thumbs Up to EVAR System

Todd Neale

June 14, 2018

News Daily News

Leg Shields May Prevent Radiation-Induced DNA Damage During EVAR

L.A. McKeown

October 25, 2017

News Daily News

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Todd Neale

September 29, 2016

News Daily News

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

July 23, 2015

News Daily News

Una 1er Estrategia EVAR en el Manejo de AAA Rotos Beneficia Precozmente la Calidad de Vida

April 17, 2015

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

Little Pre- and Postmarket Testing for Most Recalled CV Devices

FDA Safety Communication Updates Stance on Endologix AAA Grafts

Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers

More Insights Into AAA Genetics Spur New Questions on Screening

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

Women Likely Not Good Targets for AAA Screening, Study Suggests

Screening Programs for Abdominal Aortic Aneurysm Need a Rethink, Swedish Study Contends

FDA Advisory Panel Gives Thumbs Up to EVAR System

Leg Shields May Prevent Radiation-Induced DNA Damage During EVAR

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

Una 1er Estrategia EVAR en el Manejo de AAA Rotos Beneficia Precozmente la Calidad de Vida

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content